See the visionaries leading this year's London chemistry and bioinformatics tracks. Because our facilitators swap passive slide decks for active, peer-to-peer strategic debates, sponsors gain unscripted access to the immediate technical bottlenecks, tech-stack migrations, and outsourcing requirements of high-value life science accounts. Sponsor the tracks they lead to become part of the solution.
Unlike traditional large scale conferences, this Strategy Meeting is a focused, invitation-only forum that connects solution providers with directors, VPs, and decision makers driving drug discovery, bioinformatics integration, and strategic R&D investment.
Thought leadership positioning without commercial noise
Targeted engagement with senior industry leaders
Long-term relationship development with qualified stakeholders
Brand alignment with high-value, strategic scientific dialogue
Heads of Medicinal Chemistry
Heads of Drug Discovery & Biology
VP / Director of R&D
Translational Science & Pipeline Leaders
Innovation, Data & Scientific Strategy Leaders
Global pharmaceutical companies
Biotechnology innovators
Contract Research Organizations (CROs)
Scientific tool, data platform & software solution providers
Bioinformatics & Computational Strategy Leaders
Investors focusing on AI, bioinformatics and discovery platforms
Sponsors are positioned alongside discussions on mission-critical R&D challenges and innovations, such as (but not limited to):
AI / ML / Data Science
Chemical Biology, Targeted Protein Degradation & Undruggables
Target ID To Proof Of Concept
Integrated
Drug
Discovery
Private Equity, Venture Capital & Strategic Partnerships In Drug Discovery
London stands at the center of Europe’s life sciences, medicinal chemistry, and computational biology ecosystem making it the ideal host city for the Medicinal Chemistry Drug Discovery and Bioinformatics
Strategy Meeting 2026.
For sponsors, London offers more than a prestigious location—it delivers strategic influence, high-value engagement, and direct access to leaders driving medicinal chemistry, drug discovery, and bioinformatics transformation across Europe and beyond, making this meeting an essential platform for impact in 2026.
Europe’s Drug Discovery & Bioinformatics Hub : London is internationally recognised as a leading centre for medicinal chemistry innovation, AI-enabled drug discovery, and bioinformatics research. The city attracts global pharmaceutical companies, high-growth biotech firms, CROs, and advanced data-driven discovery platforms, creating an unparalleled environment for strategic scientific and commercial collaboration.
Global Connectivity & International Access : With world-class transport infrastructure and exceptional international connectivity, London provides seamless access for delegates from across Europe, North America, the Middle East, and APAC. This global accessibility maximises sponsor exposure, supports cross-border partnerships, and strengthens international business development opportunities.
Proximity to Scientific & Industry Decision-Makers : London’s dense concentration of multinational pharmaceutical headquarters, leading research universities, computational science centres, regulatory stakeholders, and investment communities places sponsors directly alongside the key decision-makers shaping the future of medicinal chemistry and bioinformatics-driven discovery.
Capital of Investment, Innovation & Partnerships : As a global financial centre with a strong venture capital and private equity presence, London plays a pivotal role in funding and scaling drug discovery innovation. Its thriving innovation clusters accelerate partnerships between academia, biotech, pharma, and technology providers—enhancing sponsor visibility at the point where science meets commercial strategy.
Strategic panel or keynote placement
Executive networking and 1:1 meeting opportunities
Brand visibility across digital and print event material
Pre-event marketing exposure to targeted attendee lists
Flexible sponsorship packages are tailored to your organisation’s objectives and resource commitment, ranging from Thought Leadership to Lead Sponsorship and Bespoke Strategic Engagement options, including:
Proventa International’s R&D Strategy Meetings have a proven history of creating valuable commercial outcomes for sponsors. Leading biotech, pharma, and solution partners describe how executive-level engagement led to pivotal collaborations and expanded market opportunities. Hear from Past Sponsors:
Don’t miss your opportunity to position your organisation at one of Europe’s most focused R&D strategy forums of 2026.
Connect with senior pharmaceutical, biotech, computational science, and investment leaders sponsor now.
Sponsoring this event places your organisation at the nexus of strategic decision-making within medicinal chemistry, drug discovery and bioinformatics driving innovation, operational transformation, and high-value commercial alliances in the UK and beyond.
We are seeking alignment with companies and partners in the following categories:
Lead Sponsor – headline strategic visibility
Partnering Sponsors – category thought leaders
Key Opinion Leaders – facilitation & discussion drivers
Media & Outreach Partners – extended industry exposure
